StemCell Institute (TSE:7096) Total Liabilities : 円4,065 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is StemCell Institute Total Liabilities?

StemCell Institute's Total Liabilities for the quarter that ended in Sep. 2024 was 円4,065 Mil.

StemCell Institute's quarterly Total Liabilities increased from Dec. 2023 (円3,707.27 Mil) to Mar. 2024 (円3,850.46 Mil) and increased from Mar. 2024 (円3,850.46 Mil) to Sep. 2024 (円4,064.75 Mil).

StemCell Institute's annual Total Liabilities increased from Mar. 2022 (円3,111.62 Mil) to Mar. 2023 (円3,513.03 Mil) and increased from Mar. 2023 (円3,513.03 Mil) to Mar. 2024 (円3,850.46 Mil).

StemCell Institute Total Liabilities Historical Data

The historical data trend for StemCell Institute's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

StemCell Institute Total Liabilities Chart

StemCell Institute Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

2,304.86

2,636.28

3,111.62

3,513.03

3,850.46

StemCell Institute Quarterly Data
	Mar18	Mar19	Dec19	Mar20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
Total Liabilities	Get a 7-Day Free Trial													3,511.58	3,665.13	3,707.27	3,850.46	4,064.75

StemCell Institute Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

StemCell Institute's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3760.022	+	(6.676	+	56.083
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	27.681	+	0)
	=	3,850

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	6543.075	-	2692.613
	=	3,850

StemCell Institute's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3966.209	+	(0	+	65.166
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	33.379	+	0)
	=	4,065

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	6935.288	-	2870.534
	=	4,065

StemCell Institute Total Liabilities Related Terms

Thank you for viewing the detailed overview of StemCell Institute's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

StemCell Institute Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » StemCell Institute (TSE:7096) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Shimbashi, Minato-ku, Tamuracho Building, Matsuoka, Tokyo, JPN, 105-0004

Website

https://www.stemcell.co.jp

StemCell Institute is engaged in Cell bank business that separates and stores cord blood for regenerative medicine. Cord blood is the baby's blood contained in the umbilical cord and placenta that connects mother and baby. In its umbilical cord blood storage business, upon receiving notification from customers who have contracted, umbilical cord blood collected at obstetric facilities throughout Japan is collected, transported to the company's own cell processing center within 48 hours, and it provides a service to store cells at ultra-low temperature after separating cells from blood.

StemCell Institute Headlines

No Headlines